Jupiter Neurosciences, Inc. (JUNS) vs NEXGEL, Inc. (NXGL)

A side-by-side comparison of Jupiter Neurosciences, Inc. and NEXGEL, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — JUNS vs NXGL

growth of $100 · dividends reinvested · last 2y
JUNS -99.4% (-92.3%/yr)NXGL -95.2% (-78.1%/yr)NXGL compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $10020252026$1$5
JUNS NXGL

JUNS vs NXGL: by the numbers

  • •NXGL is the larger company ($1M vs $1M market cap).
  • •Both run net losses; NXGL's is the smaller (-51.26% vs -14220.12% net margin).
  • •NXGL grew revenue faster over the past five years (63.69% vs -47.77% CAGR).

Metrics side by side

Valuation

MetricJUNSNXGL
P/S ratio19.250.12
P/B ratioN/A0.29

Profitability

MetricJUNSNXGL
Gross margin88.34%35.07%
Operating margin-40873.19%-29.35%
Net margin-14220.12%-51.26%
ROEN/A-124.97%
ROIC-709.40%-41.80%

Growth (annualized)

MetricJUNSNXGL
Revenue CAGR (5Y)-47.77%63.69%

Frequently asked

Which has grown faster, JUNS or NXGL?
Over the past five years, NXGL grew revenue faster — JUNS at a -47.77% CAGR versus NXGL at 63.69%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.